FB Bancorp Details Annual Meeting Proposals, Significant Director Equity Awards
FBLA sits 40% above its 52-week low of $9.81.
Summary
FB Bancorp filed its definitive proxy statement for the annual meeting, detailing routine proposals and significant equity compensation for non-employee directors, totaling over $5.4 million in 2025.
Key Events · Corporate Governance and Compliance · FBLA
-
Annual Meeting Scheduled
The annual meeting of stockholders will be held on April 29, 2026, to vote on director elections and auditor ratification.
-
Director Elections Proposed
Three directors, J. Luis Baños, Jr., Gerard W. Barousse, Jr., and Mark C. Romig, are nominated for election to serve three-year terms.
-
Significant Director Equity Compensation
Non-employee directors received substantial equity awards in 2025, with aggregate grant date fair values exceeding $5.4 million in stock and option awards, vesting over five years.
-
Executive Compensation and Severance Detailed
The filing provides comprehensive compensation data for named executive officers and outlines employment agreements, including change-in-control severance provisions for the CEO and Executive Chairman.
Analysis · FBLA · Finance
This definitive proxy statement outlines the agenda for FB Bancorp's upcoming annual meeting, including the election of three directors and the ratification of its independent auditor. A notable aspect is the substantial equity compensation awarded to non-employee directors in 2025, totaling over $5.4 million in stock and option awards. This represents a significant compensation package relative to the company's market capitalization and provides insight into executive and board incentives following the company's recent return to net income, as reported in its 10-K filing on March 26, 2026. Investors should review these compensation details as they impact future share dilution and overall shareholder value.
At the time of this filing, FBLA was trading at $13.75 on NASDAQ in the Finance sector, with a market capitalization of approximately $272.8M. The 52-week trading range was $9.81 to $14.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.